98%
921
2 minutes
20
Background: Diabetic foot ulcer (DFU) is a common and challenging chronic disease that can lead to non-traumatic amputation. Studies have indicated that complex cellular environments in DFU often lead to the dysfunction of several cells at the wound site; however, the mechanism of this injury is still difficult to elucidate.
Methods: DFU and normal skin tissue from patients were analyzed by pathological examination using hematoxylin and eosin (H&E), Masson, myeloperoxidase (MPO) and 8-Oxo-2'-deoxyguanosine (8OHdG) immunohistochemical staining. Extract and identify adipose-derived stem cell (ADSC) exosomes from ADSC culture medium. A diabetic wound healing model and a high-glucose-induced fibroblast cell model were used to analyze the effects of ADSC exosomes on DFU wound healing. In addition, collagen synthesis and fibrosis-related molecules as well as oxidative stress-related indices were detected in the cell model. To uncover the underlying mechanism, we further detected the expression of antioxidant related molecules, including Kelch-like ECH-associated protein 1 (Keap1), nuclear factor erythroid 2-related factor 2 (Nrf2), hemeoxygenase-1 (HO-1), and glutathione peroxidase 4 (GPX4).
Results: Pathological examination confirmed that DFU tissue displayed increased inflammatory cell infiltration and cell injury compared to normal skin. We confirmed that ADSC exosomes accelerated DFU wound healing and improved collagen synthesis and deposition. ADSC exosomes could reverse high glucose induced fibroblast damage, as well as the ability of collagen synthesis. Furthermore, our results indicated that ADSC exosomes improved HG-induced oxidative stress injury by regulating the expression of the Keap1/Nrf2 axis.
Conclusions: This study revealed that ADSC exosomes alleviated HG-induced fibroblast injury and accelerated diabetic wound healing by regulating the expression of the Keap1/Nrf2 axis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cellsig.2025.111936 | DOI Listing |
Int Immunopharmacol
September 2025
Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China; Tianjin General Surgery Institute, Tianjin, China; Tianjin Key Laboratory of Precise Vascular Reconstruction and Organ Function Repair, Tianjin, China. Electronic address:
Background: Intestinal ischemia/reperfusion injury (IRI) is a severe clinical condition associated with high morbidity and mortality. Despite advances in understanding the pathophysiology of IRI, effective therapeutic strategies remain limited. Adipose stem cell (ADSC)-derived exosomes (Exo) have been proven to be appropriate candidates for IRI through the anti-inflammatory effects.
View Article and Find Full Text PDFBMC Urol
August 2025
Department of Pharmacology, Ankara University Faculty of Pharmacy, Ankara, Turkey.
Erectile dysfunction (ED) is a pervasive condition projected to affect some 322 million men worldwide by 2025, profoundly impairing quality of life and psychosocial well‑being. Current therapies-most notably phosphodiesterase‑5 inhibitors and mechanical devices-offer only transient, symptomatic relief and do not repair the underlying vascular, smooth muscle, and neural degeneration driving ED, particularly in diabetic and neurogenic subtypes. Emerging non‑cellular modalities (e.
View Article and Find Full Text PDFIran J Basic Med Sci
January 2025
Department of Cardiology, Xinghua People's Hospital Affiliated to Yangzhou University, Xinghua, Jiangsu 225700, China.
Objectives: Atrial fibrillation (AF) is a prevalent arrhythmia accompanied by structural and electrical remodeling of the heart. Here, we examined the possible mechanisms behind the protective role of adipose-derived stem cell (ADSC)-derived exosomes in AF therapy.
Materials And Methods: We isolated exosomes from ADSCs.
Int J Surg
July 2025
Department of Plastic Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taiwan.
Adipose-derived stem cell exosomes (ADSC-Exos) have emerged as promising cell-free therapeutic agents in regenerative medicine, offering many benefits of stem cell therapy without the risks of cell transplantation. These nanoscale vesicles (30-150 nm) contain bioactive cargo including proteins, microRNAs, and lipids that mediate tissue repair through multiple mechanisms: promoting angiogenesis, modulating inflammation, reducing fibrosis, and activating endogenous regenerative pathways. Recent preclinical studies demonstrate remarkable efficacy across diverse applications, from accelerating chronic wound healing and stimulating skin regeneration to repairing cartilage, bone, and nerve tissues.
View Article and Find Full Text PDFBiochem Genet
July 2025
Department of Cardiology, Guangxi International Zhuang Medicine Hospital, Nanning, Guangxi, China.
Myocardial infarction (MI) is a major health problem and is the leading cause of death worldwide. Accumulation studies confirm that exosomes derived from stem cells have been shown to effectively repair MI injury-induced cardiomyocyte damage. However, the cardioprotective benefits of adipose tissue-derived mesenchymal stem cell (ADSC)-Exos remain unclear.
View Article and Find Full Text PDF